"Le Nouvel Hôpital privé les Franciscaines (NHPF) est un établissement de santé privé de court séjour MCO du groupe ELSAN, situé au cœur de l’agglomération nîmoise. Il fait partie avec la Polyclinique Grand Sud (PGS) située également sur Nîmes et la Nouvelle Clinique Bonnefon (NCB) située sur Alès de l’entité les « Nouvelles Cliniques Nîmoises » (NCM). Ce réseau d’établissements privés favorise le déploiement de filières d’excellence permettant de répondre aux besoins de santé sur le territoire. L'établissement regroupe les activités chirurgicales suivantes : chirurgie cardiaque, vasculaire et thoracique ; neurochirurgie ; chirurgie du crâne et de l'encéphale ; chirurgie ophtalmologique, ORL et maxillo-faciale."

During the past decade, Hôpital Privé Les Franciscaines conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé Les Franciscaines" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Baim Institute for Clinical Research" with 1 trials sponsored, "CID - Carbostent & Implantable Devices" with 1 trials sponsored, "Centre Chirurgical Marie Lannelongue" with 1 trials sponsored and "Elsan" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé Les Franciscaines" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centre Hospitalier Régional Universitaire Montpellier" with 1 trials as a collaborator and "Centre Hospitalo-Universitaire de Brabois, Vandoeuvre Les Nancy, France" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé Les Franciscaines" are "Coronary Artery Disease" (3 trials), "Angioplasty, Transluminal, Percutaneous Coronary" (2 trials), "Atrial Fibrillation" (2 trials), "Aortic Arch; Aneurysm, Dissecting" (1 trials) and "Arrhythmia" (1 trials). Many other conditions were trialed in "Hôpital Privé Les Franciscaines" in a lesser frequency.

Most popular intervention types in "Hôpital Privé Les Franciscaines" are "Device" (7 trials), "Procedure" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "3D printing" (1 trials), "Angioplasty (PROMUS Element™, and Xience™ Prime stent)" (1 trials), "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials), "DES Limus Carbostent" (1 trials) and "Otamixaban (XRP0673)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé Les Franciscaines" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Privé Les Franciscaines". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hôpital Privé Les Franciscaines, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé Les Franciscaines, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".